Saturday 17 October 2026
Export PAVM’s income statement to Excel — free account
PAVmed Inc.
PAVM Healthcare Medical Devices
PAVmed Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71,000.00, down 97.6% from fiscal 2024. In the quarter to June 2026, revenue grew 450.0%, EPS grew 96.1% and free cash flow fell 125.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
2.41
0.02
−0.82%
Follow PAVM
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | 4 | 5 | 2 |
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.23 | 0.91 |
P/S ratio |
— | — | — | — | — | 0.00 | 64.39 | 11.96 | 2.03 | 62.61 |
Altman Z-Score |
— | — | — | — | — | 11.87 | (10.82) | (19.99) | (17.54) | (11.40) |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | 7.29 | (24.52) | (49.26) | (44.18) | (26.17) |
P/Operating CF |
— | — | — | — | — | (11.36) | (2.59) | (2.47) | 64.62 | (2.87) |
P/B ratio |
— | — | — | — | — | 2.48 | 5.29 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | — | 2.54 | 9.09 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | — | 0.00 | 8.41 | 5.32 | 2.75 | 88.03 |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | (3.13) | (0.08) | (0.25) | (0.25) | (1.20) |
EV/FCF |
— | — | — | — | — | (3.02) | (0.08) | (0.25) | (0.25) | (1.28) |
Quick Ratio |
0.49 | 0.60 | 0.75 | 0.52 | 0.85 | 10.25 | 0.97 | 0.36 | 0.03 | 0.10 |
Current Ratio |
0.62 | 0.64 | 0.77 | 0.55 | 0.94 | 10.93 | 1.07 | 0.45 | 0.06 | 0.17 |
Net Debt/EBITDA |
0.10 | (0.05) | 0.92 | 0.44 | 0.74 | 1.43 | 0.45 | 0.30 | 0.03 | 0.07 |
Debt/Assets |
0.00% | 118.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | (0.68) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.06 | 0.09 | 0.00 |
Operating CF/Net income |
0.79 | 0.64 | 0.47 | 0.80 | 0.63 | 0.80 | 0.80 | 0.79 | (1.05) | 1.38 |
Capex/Depreciation |
(5.74) | (0.01) | (0.02) | (1.93) | (2.39) | (6.50) | (0.63) | 0.26 | 0.25 | (0.30) |
Interest Coverage |
— | (11.09) | (4.42) | (433.18) | (440.58) | — | (71.11) | (116.80) | (988.60) | (1,038.38) |
| (3,590.15%) | 495.14% | 447.03% | 292.38% | 695.15% | (136.86%) | (209.45%) | 706.05% | (171.12%) | 59.31% | |
| (542.18%) | (828.50%) | (369.98%) | (212.59%) | (255.85%) | (94.85%) | (126.66%) | (152.17%) | 100.24% | (10.86%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,573.87%) | 0.00% | 0.00% | 0.00% | (65.64%) |
Return on Tangible Assets |
1,313.25% | 1,150.11% | 757.27% | 313.77% | 2,814.58% | (66.04%) | (1,724.24%) | 237.56% | (96.48%) | 30.93% |
Average Days of Receivables |
— | — | — | — | — | 146.00 | 16.46 | 9.08 | 2.19 | 77.11 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3,969.40% | 6,720.95% | 582.22% | 198.06% | 6,326.76% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6,863.00% | 16,108.22% | 1,979.20% | 1,207.05% | 24,178.87% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | 0.04 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3,001.80% | 5,180.90% | 454.28% | 215.33% | 2,404.23% |
Graham Net Nets |
— | — | — | — | — | 0.39 | 0.02 | (1.11) | (5.85) | (3.14) |
Graham Number |
— | — | — | — | — | 0.00 | 0.00 | 840.75 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | (25.22%) | (206.23%) | (229.94%) | 436.74% | 109.83% |
Free Cash Flow Yield |
— | — | — | — | — | (22.06%) | (166.37%) | (174.83%) | (547.56%) | (109.93%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.90 | 1.91 | 10.18 | 9.29 | 0.11 |
Operating CF per Share |
(154.68) | (220.27) | (177.53) | (199.06) | (207.91) | (235.72) | (359.05) | (216.10) | (104.08) | (7.76) |
Capex per Share |
(0.76) | (0.18) | (0.54) | (0.40) | (0.52) | (8.53) | (7.79) | 3.15 | 0.92 | (0.05) |
Free Cash Flow per Share |
(155.44) | (220.45) | (178.07) | (199.46) | (208.43) | (244.25) | (366.84) | (212.95) | (103.16) | (7.81) |
Cash per Share |
20.34 | 51.17 | 166.10 | 92.68 | 163.72 | 448.65 | 201.03 | 81.56 | 3.68 | 2.29 |
Shareholders Equity per Share |
(11.08) | (94.95) | (50.02) | (69.12) | (4.49) | 461.20 | 55.31 | (99.74) | (21.81) | 33.26 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(11.08) | (94.95) | (50.02) | (69.12) | (4.49) | 461.20 | 55.31 | (99.74) | (21.81) | 33.26 |
Free Cash Flow |
(4.48) | (6.61) | (8.81) | (13.38) | (21.97) | (42.06) | (72.52) | (51.28) | (33.26) | (5.24) |
Working Capital |
(0.45) | (0.92) | (2.51) | (5.33) | (1.31) | 75.08 | 2.73 | (29.68) | (33.28) | (12.28) |
Capital Expenditures |
(0.02) | (0.01) | (0.03) | (0.03) | (0.05) | (1.47) | (1.54) | 0.76 | 0.30 | (0.03) |
Net Current Asset Value |
(0.45) | (2.86) | (2.51) | (5.33) | (1.31) | 75.08 | 0.88 | (32.64) | (35.53) | (13.95) |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.94 | 4.08 | (0.31) | (0.10) | 0.44 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.21 | 21.90 | 44.52 | 0.00 | 0.28 | 0.14 | 1.00 | 1.64 | 7.93 | 1.36 |
Cash ROIC |
(1,679.18%) | (1,048.26%) | (153.41%) | (846.55%) | (130.90%) | (26.85%) | (143.11%) | 1,171.00% | 568.72% | (21.97%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 3.47 | 62.87 | 75.82 | 4.30 |
Accounts Payable Turnover |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.19 | 1.20 | 2.86 | 3.96 | 0.33 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.01 | 0.00 | 0.00 |
Average Days of Payables |
91,192.37 | 44,391.20 | 64,761.43 | 60,482.04 | 47,069.13 | 2,058.35 | 273.09 | 101.54 | 49.55 | 1,135.18 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.21 | 15.81 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | 0.11 | 0.04 | 0.04 | 0.02 |
Average Payables |
0.56 | 0.91 | 1.30 | 2.05 | 2.66 | 3.13 | 3.00 | 2.25 | 1.22 | 0.67 |
Average Inventory |
— | — | — | — | — | — | — | 0.19 | — | — |
Average Assets |
1.04 | 1.26 | 5.07 | 7.87 | 13.51 | 53.38 | 70.48 | 43.55 | 31.89 | 34.74 |
Average Common Equity |
0.16 | (2.10) | (4.19) | (5.72) | (4.97) | 36.99 | 42.62 | (9.39) | (18.68) | (6.36) |
Columns are period end dates